Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Biogen Inc. (NASDAQ:BIIB) Shares Bought by Macquarie Group Ltd.
Credicorp Ltd. (NYSE:BAP) Shares Bought by Macquarie Group Ltd.
Finally, Macquarie Group Ltd. increased its position in Webster Financial by 0.6% during the second quarter.
Finally, Macquarie Group Ltd. lifted its holdings in shares of Veradigm by 7.1% in the 3rd quarter.
Finally, Macquarie Group Ltd. purchased a new stake in Agiliti during the second quarter worth $28,000.
Source: https://www.etfdailynews.com/2023/04/18/analysts-set-agiliti-inc-nyseagti-pt-at-19-86/
Finally, Macquarie Group Ltd. raised its holdings in Vertex Pharmaceuticals by 232.3% in the 2nd quarter.
Finally, Macquarie Group Ltd. raised its stake in DiamondRock Hospitality by 1.3% in the third quarter.
Macquarie Group Limited (ASX:MQG) and Wavenet Limited completed the acquisition of AdEPT Technology Group plc (AIM:ADT) from a group of seller and others.
Macquarie Group Ltd. acquired a new stake in Asure Software in the first quarter valued at $42,000.
Macquarie Group Ltd. bought a new position in shares of Cytek Biosciences in the 4th quarter valued at approximately $10,748,000.
Macquarie Group Ltd. cut its stake in Virtu Financial, Inc. () by 1.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.
Macquarie Group Ltd. Decreases Stock Position in Lennar Co.
Macquarie Group Ltd. grew its holdings in shares of Consensus Cloud Solutions by 12.3% during the third quarter.
Macquarie Group Ltd. increased its holdings in shares of FOX by 9.7% in the 4th quarter.
Macquarie Group Ltd. increased its position in Cenovus Energy by 12.5% during the fourth quarter.
Macquarie Group Ltd. lifted its position in Salesforce, Inc. () by 3.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Macquarie Group Ltd. now owns 1,132,619 shares of the biotechnology company’s stock worth $190,688,000 after acquiring an additional 30,818 shares during the last quarter.
Macquarie Group Ltd. now owns 114,182 shares of the biopharmaceutical company’s stock valued at $1,743,000 after purchasing an additional 552 shares in the last quarter.
Macquarie Group Ltd. now owns 1,362,366 shares of the medical device company’s stock worth $53,297,000 after purchasing an additional 5,835 shares in the last quarter.
Macquarie Group Ltd. now owns 1,463,456 shares of the industrial products company’s stock worth $38,284,000 after purchasing an additional 26,221 shares in the last quarter.